Please login to the form below

Not currently logged in
Email:
Password:

prescription medicines

This page shows the latest prescription medicines news and features for those working in and with pharma, biotech and healthcare.

GSK: we won’t be splitting up any time soon

GSK: we won’t be splitting up any time soon

prescription medicines businesses. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance personalised medicines research throughout its pipeline.

Latest news

More from news
Approximately 2 fully matching, plus 221 partially matching documents found.

Latest Intelligence

  • Legal and regulatory affairs

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    phrases. For healthcare companies, it was the same. However, it started to change when the ABPI established the Prescription Medicines Code of Practice Authority (PMCPA) in 1993 to operate the Code ... At the time, they knew the campaign would test the

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    If successful, however, these arrangements could be expanded to encompass a broader range of medicines. ... Bulgaria and Romania have been working together since 2014 to explore opportunities to reduce the prices they pay for their prescription medicines.

  • Market access improvements in Turkey Market access improvements in Turkey

    Almost the entire pharmaceutical market is made up of prescription medicines (93.8%) with 87% reimbursed. ... While welcoming the promise of a slight acceleration of review time with high priority medicines, industry is disappointed that orphan drugs and

  • From two final medical signatories to one From two final medical signatories to one

    The change was prompted to bring the code in line with the European Federation for Pharmaceutical Industry Associations (EFPIA) Code on the promotion of prescription-only medicines. ... The Prescription Medicines Code of Practice Authority (PMCPA)

More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.

Latest appointments

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    He also brings experience form Boehringer Ingelheim, where he was director of its UK Change Project, head of UK market access for prescription medicines, and held a series of marketing management

  • Pink Carrots appoints art director Pink Carrots appoints art director

    Pink Carrots, which recently won the prescription medicines category at the GWA HealthCare Awards 2014, also made three other hires.

  • IPHA names Janssen's Dr Leisha Daly as president IPHA names Janssen's Dr Leisha Daly as president

    Daly, who has also been a member of IPHA's board of directors since June 2012, was reappointed to the Association's Prescription Medicines Division Strategy Board in August 2012.

  • Isgro boosts senior team Isgro boosts senior team

    Weber's healthcare agency experience ranges from prescription and over the counter medicines to veterinary medicine (both small and livestock). She studied Spanish and Portuguese literature at the Goethe Universität Frankfurt,

  • Boehringer names new UK MD Boehringer names new UK MD

    She has since held senior management roles at Boehringer across the globe, including spells as head of human pharma in Denmark, managing director in Turkey and head of prescription medicines and ... Most recently Krumins served at Boehringer's operations

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics